FDA seeks input on 'new paradigm' of moving drugs from Rx to OTC
This article was originally published in Scrip
Executive Summary
The US FDA is considering under what conditions and what types of technologies could be used to make prescription medicines safely available to consumers over-the-counter (OTC) without a doctor's script, and wants to hear ideas from the industry, the pharmacy community and other stakeholders at a two-day meeting in March.